TAXUS® Express 2
Company
Angiotech Pharmaceuticals and Boston Scientific
Use
Paclitaxel-eluting stent used to prevent restenosis after ballon angioplasty of coronary peripheral arteries
Features
Largest 1st year sales of any FDA approved product in U.S. history
NIH Contribution
Discovered that localized release of paclitaxel prevents artery narrowing from cell growth
Approval Type
FDA
HHS Institute/Agency
NIA
Inventor(s)
J. Kinsella and S. Sollott
Year
2004
Tech Cat
Device
Request More Info
